Stocks to invest in – 13D Filing: Icahn Capital Praises Xerox Corp (XRX) Split in Filing, Lands Board Seats

Stocks to invest in

At Insider Monkey, we closely monitor the moves made by activist investors, and Carl Icahn of Icahn Capital LP is without a doubt the most prominent of those. Icahn Capital recently filed a 13D related to its Xerox Corp (NYSE:XRX) holding, in which the firm disclosed a number of things, including a change to its holding and an agreement reached with Xerox following the company’s decision to split into two businesses, which was announced this morning. As part of the agreement, Icahn Capital will land a trio of board seats. You can see the main filing below, as well as access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
High River Limited Partnership 18,475,408 0 18,475,408 0 18,475,408 1.82%
Hopper Investments LLC 0 18,475,408 0 18,475,408 18,475,408 1.82%
Barberry Corp. 0 18,475,408 0 18,475,408 18,475,408 1.82%
Icahn Partners Master Fund LP 30,708,164 0 30,708,164 0 30,708,164 3.03%
Icahn Offshore LP 0 30,708,164 0 30,708,164 30,708,164 3.03%
Icahn Partners LP 43,193,471 0 43,193,471 0 43,193,471 4.27%
Icahn Onshore LP 0 43,193,471 0 43,193,471 43,193,471 4.27%
Icahn Capital LP 0 73,901,635 0 73,901,635 73,901,635 7.30%
IPH GP LLC 0 73,901,635 0 73,901,635 73,901,635 7.30%
Icahn Enterprises Holdings L.P. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Icahn Enterprises G.P. Inc. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Beckton Corp. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Carl C. Icahn 0 92,377,043 0 92,377,043 92,377,043 9.12%
Date of Transaction Amount of Securities Price Per Share High River Limited Partnership

Carl Icahn

Icahn Capital LP

Page 1 of 16 SEC Filing


Washington, D.C. 20549


Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Xerox Corporation

(Name of Issuer)

Common Stock, $1 par value

(Title of Class of Securities)


(CUSIP Number)

Jesse Lynn, Esq.

Icahn Capital LP

767 Fifth Avenue, 47th Floor

New York, New York 10153

(212) 702-4300

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

January 28, 2016

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /.

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d‑7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Xerox Corp (NYSE:XRX)

Biotech Insider Alert – $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund’s #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it’s sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

– Stocks to invest in

Start trading now on the best platform on the market.

Source link